Josefin Ahnström/LinkedIn; Christina Crossette-Thambiah/ profiles.imperial.ac.uk
May 29, 2026, 04:37
Josefin Ahnström: How Andexanet Alfa Impacts TFPIα Function
Josefin Ahnström, Associate Professor in Haematology at Imperial College London, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
”I am happy to share our most recent paper, published in Blood Advances, where we have investigated how Andexanet alfa impacts TFPI alpha function.
Amazing work Christina Crossette-Thambiah!
Thank you for all heart and hard work you’ve put into this project.”
Title: TFPIα inhibition by Andexanet alfa is partially restored by protein S and factor V-short
Authors: Christina Keshini Crossette-Thambiah, Krister Bamberg, Mike A Laffan, Josefin Ahnstrom
Stay updated on all scientific advances with Hemostasis Today.
-
May 29, 2026, 03:19Building Safer Systems for Anticoagulation Management – ISTH
-
May 29, 2026, 03:07Early Diagnosis Can Change the Lives of Women With Haemophilia – EHC
-
May 29, 2026, 02:41Ifeanyichukwu Ifechidere: The Biggest DOAC Myth in Coagulation – ‘No Monitoring Required’
-
May 29, 2026, 02:35Mariam Swidan: Why Is LDH the ‘Tattletale’ of the Lab?
-
May 29, 2026, 02:20Yuntian Wang: Multi-View Learning for Predicting Avatrombopag Response in Pediatric Immune Thrombocytopenia
-
May 29, 2026, 01:57Giuseppina Caligiuri: Pathophysiological Challenges and Emerging Therapeutic Strategies in Acute Stroke
-
May 28, 2026, 23:47Hussnain Javaid: The Importance of Targeted Examination in Iron Deficiency Anaemia
-
May 28, 2026, 23:47ASH Heads to ASCO26 with Career Opportunities and Global Hematology Leadership
-
May 28, 2026, 23:46Armenia Takes Center Stage in Global Hemophilia Initiative – Yeolyan Hematology and Oncology Center